Cue Biopharma
38 hedge funds and large institutions have $26.7M invested in Cue Biopharma in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
38% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 16
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.26M | |
| 2 | +$334K | |
| 3 | +$325K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$292K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$118K |
Top Sellers
| 1 | -$212K | |
| 2 | -$152K | |
| 3 | -$108K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$91.1K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$91K |